Eqis Capital Management, Inc. Amneal Pharmaceuticals, Inc. Transaction History

Eqis Capital Management, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$3.95 - $5.42 $51,705 - $70,947	-13,090 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$3.54 - $5.27 $6,248 - $9,301	-1,765 Reduced 11.88%	13,090 $51,000
Q2 2020 Aug 10, 2020	SELL	$2.87 - $5.46 $3,380 - $6,431	-1,178 Reduced 7.35%	14,855 $71,000
Q1 2020 May 12, 2020	BUY	$2.46 - $5.35 $351 - $765	143 Added 0.9%	16,033 $78,000
Q4 2019 Jan 24, 2020	SELL	$2.65 - $5.56 $4,197 - $8,807	-1,584 Reduced 9.06%	15,890 $77,000
Q3 2019 Nov 05, 2019	SELL	$2.29 - $7.1 $6,620 - $20,526	-2,891 Reduced 14.2%	17,474 $51,000
Q2 2019 Jul 18, 2019	SELL	$6.44 - $14.29 $14,477 - $32,123	-2,248 Reduced 9.94%	20,365 $146,000
Q1 2019 Apr 18, 2019	SELL	$11.87 - $14.84 $56,797 - $71,009	-4,785 Reduced 17.46%	22,613 $320,000
Q4 2018 Jan 25, 2019	SELL	$13.09 - $21.49 $26,088 - $42,829	-1,993 Reduced 6.78%	27,398 $371,000
Q3 2018 Oct 17, 2018	BUY	$16.4 - $24.27 $9,544 - $14,125	582 Added 2.02%	29,391 $691,000
Q2 2018 Jul 27, 2018	BUY	$13.95 - $20.2 $401,885 - $581,941	28,809 New	28,809 $473,000

185

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.25B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Eqis Capital Management, Inc. with notifications on news.